Close Pipeline immuno-oncology Collaboration Programs Discovery Candidate Preclinical Clinical Partner A2aR/A2bR antagonist EP4R antagonist (DT-9081) Anti-CCR8 antibody Undisclosed GPCR targets Pipeline Partnering Opportunities Resources Careers Contact us 77/100 2021 #Discovermorethanyouthink Strasbourg - Illkirch Domain Therapeutics SA Bioparc 1 - 850 Boulevard Sébastien Brant 67400 Strasbourg - Illkirch - France https://www.domaintherapeutics.com/ Montreal Domain Therapeutics NA Inc. Neomed Institute - 7171 Frédérick Banting H4S 1Z9 Montreal - Canada https://www.domaintherapeutics.ca/ © 2021 Domain Therapeutics - All rights reserved Privacy Legal notices RSS Axeptio consent

Pipeline Close Domain Therapeutics reaches two milestones in multi-target research collaboration with Boehringer Ingelheim Less than one year after signing agreement, the GPCR expert has reached key discovery milestones in two independent projects Strasbourg, France, September 30, 2019 – Domain Therapeutics, a biopharmaceutical company specialized in the discovery and development of new drug candidates targeting transmembrane receptors in neurology, oncology and rare diseases, today announces the achievement of two discovery milestones in its multi-target collaboration with Boehringer Ingelheim. These milestones illustrate the ability of Domain Therapeutics to address orphan GPCRs using its proprietary platforms, DTect-All™ and bioSens-All™. Financial details were not disclosed. “Collaborating with a partner such as Boehringer Ingelheim is a great opportunity and another excellent endorsement of our expertise with challenging GPCRs,” said Pascal Neuville, CEO of Domain Therapeutics. “We are very proud to have achieved, on time, the two first milestones of this collaboration and we look forward to building on this success.” The two companies pursue the collaboration on the ongoing projects with the final objective to nominate preclinical candidates for the treatment of neuropsychiatric diseases. Download the pdf Pipeline Partnering Opportunities Resources Careers Contact us 77/100 2021 #Discovermorethanyouthink Strasbourg - Illkirch Domain Therapeutics SA Bioparc 1 - 850 Boulevard Sébastien Brant 67400 Strasbourg - Illkirch - France https://www.domaintherapeutics.com/ Montreal Domain Therapeutics NA Inc. Neomed Institute - 7171 Frédérick Banting H4S 1Z9 Montreal - Canada https://www.domaintherapeutics.ca/ © 2021 Domain Therapeutics - All rights reserved Privacy Legal notices RSS Axeptio consent